2,079 research outputs found
Hadron Physics at KLOE and KLOE-2
The KLOE Collaboration completed the full data taking on March 2006,
acquiring 2.5 fb ^ -1 at the peak of the \phi and other 240 pb ^ -1 off-peak. A
new Collaboration is working on a new project, called KLOE-2, to refine and
extend the KLOE physics program. We present here some preliminary and published
results from the KLOE Collaboration on the pseudoscalar \eta meson and the
study of \gamma \gamma processes, that are among the main points of the KLOE-2
physics program.Comment: Presented at Hadron 201
eta - eta prime Mixing -From electromagnetic transitions to weak decays of charm and beauty hadrons
It has been realized for a long time that knowing the eta and eta^prime wave
functions in terms of quark and gluon components probes our understanding of
non-perturbative QCD dynamics. Great effort has been given to this challenge --
yet no clear picture has emerged even with the most recent KLOE data. We point
out which measurements would be most helpful in arriving at a more definite
conclusion. A better knowledge of these wave functions will significantly help
to disentangle the weight of different decay subprocesses in semi-leptonic
decays of D+, Ds^+ and B+ mesons. The resulting insights will be instrumental
in treating even non-leptonic B transitions involving eta and eta^prime and
their CP asymmetries; thus they can sharpen the case for or against New Physics
intervening there.Comment: 22 pages, 4 figures; it matches published versio
Ishodi mjerenja kloe za radijativne raspade Ď u skalarne i pseudoskalarne mesone
We review recently published and preliminary results from the KLOE Collaboration on scalar and pseudoscalar mesons. We present the extraction of fundamental f0(980) and a0(980) parameters from the MĎĎ and MÎˇĎ spectrum with the first U.L. evaluation on the Ď â K0KÂŻ0Îł branching ratio. Concerning the pseudoscalar sector we present the results on Ρ âΡ Ⲡmixing and Ρ Ⲡgluonic content, with the most precise measurement of the Ρ mass and the investigation of the Ρ â ĎĎĎ dynamics from the Dalitz plot analysis. The study of the cross section for the processes e +e â â Ď +Ď âĎ 0Ď 0/Ď0Ď 0Îł allow us to measure the OZI G-parity violating strongly suppressed decay Ď â ĎĎ0.Dajemo pregled nedavno objavljenih i prethodnih ishoda mjerenja Suradnje KLOE za skalarne i pseudoskalarne mezone. Predstavljamo izvoÄenje osnovnih parametara f0(980) i a0(980) iz spektra MĎĎ i MÎˇĎ i dajemo prvu gornju granicu za omjer grananja Ď â K0KÂŻ0Îł. Ĺ to se tiÄe pseudoskalara, dajemo ishode za mijeĹĄanje Ë Îˇ âΡ Ⲡi za gluonski sadrĹžaj u Ρ Ⲡ, s najtoÄnijim mjerenjem mase Ρ i istraĹživanjem dinamike Ρ â ĎĎĎ primjenom analize Dalitzovim dijagramom. ProuÄavanje udarnih presjeka procesa e +e â â Ď +Ď âĎ 0Ď 0/Ď0Ď 0Îł omoguÄilo je odreÄivanje raspada Ď â ĎĎ0 koji je snaĹžno potisnut jer naruĹĄava OZI i G-parnost
Measurement of dijet cross-sections in pp collisions at 7 TeV centre-of-mass energy using the ATLAS detector
Double-differential dijet cross-sections measured in pp collisions at the LHC with a 7 TeV centre-of-mass energy are presented as functions of dijet mass and half the rapidity separation of the two highest-p(T) jets. These measurements are obtained using data corresponding to an integrated luminosity of 4.5 fb(-1), recorded by the ATLAS detector in 2011. The data are corrected for detector effects so that cross-sections are presented at the particle level. Cross-sections are measured up to 5 TeV dijet mass using jets reconstructed with the anti-k(t) algorithm for values of the jet radius parameter of 0.4 and 0.6. The cross-sections are compared with next-to-leading-order perturbative QCD calculations by NLOJet++ corrected to account for non-perturbative effects. Comparisons with POWHEG predictions, using a next-to-leading-order matrix element calculation interfaced to a parton-shower Monte Carlo simulation, are also shown. Electroweak effects are accounted for in both cases. The quantitative comparison of data and theoretical predictions obtained using various parameterizations of the parton distribution functions is performed using a frequentist method. In general, good agreement with data is observed for the NLOJet++ theoretical predictions when using the CT10, NNPDF2.1 and MSTW 2008 PDF sets. Disagreement is observed when using the ABM11 and HERAPDF1.5 PDF sets for some ranges of dijet mass and half the rapidity separation. An example setting a lower limit on the compositeness scale for a model of contact interactions is presented, showing that the unfolded results can be used to constrain contributions to dijet production beyond that predicted by the Standard Model
Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives
Objective: This study aims to analyze the available data on prevention and early diagnosis in gynecological cancers. Mechanism: A comprehensive search was performed in the PubMed (MEDLINE), EMBASE, SCOPUS and Web of Science databases. Findings in Brief: To date the prevention programmes of all degrees exist exclusively for cervical cancer. Human Papilloma Virus (HPV) vaccination prevents from infection and development of precancerous lesions and contributes significantly to the deflection of the incidence of cervical cancer. Screening for HPV-related lesions is worldwide performed by cervical smear (Pap-test) and HPV test. Finally, tertiary prevention is aimed at the treatment of previously diagnosticated lesions with the aid of surgery, chemotherapy, radiotherapy and immunotherapy. Unfortunately, to date the prevention programmes of other gynecological tumors have not reached a good performance; indeed, the primum movens that leads to the development of such neoplasms has not been identified yet. Actually, no screening programs for the early diagnosis of endometrial cancer are available, however, it is recommended the adoption of a healthy lifestyle and a balanced diet. Diagnostic biomarkers would be helpful for screening asymptomatic high-risk women, but histopatological examinations remain the gold standard for diagnosis of endometrial cancer. Similarly, there are no screening tests for the diagnosis of ovarian cancer. In recent years many steps forward have been made in this field and new perspectives have been presented, however, additional investigation is needed to optimize the duration and timing of treatment, examine its cost-effectiveness, and identify potential tumor or host biologic factors predictive of the efficacy and adverse events. Finally, there are no primary and secondary prevention for vulvar cancer so patients should be invited to self-examination and pay attention to the presence of symptoms. Conclusions: Are the available screening programs for the diagnosis of gynecological carcinomas sufficient? The prevention and the diagnosis of precancerous lesions is the goal to be achieved for all gynecological cancers in order to improve patient outcomes, reduce the costs for managing the disease and prolonged follow up
Diagnosis, treatment, and follow-up of a case of Wolman disease with hemophagocytic lymphohistiocytosis
: Wolman Disease (WD) is a severe multi-system metabolic disease due to lysosomal acid lipase (LAL) deficiency. We report on a WD infant who developed an unusual hemophagocytic lymphohistiocytosis (HLH) phenotype related to WD treated with sebelipase alfa. A male baby came to our attention at six months of life for respiratory insufficiency and sepsis, abdominal distension, severe hepatosplenomegaly, diarrhea, and severe growth retardation. HLH was diagnosed and treated with intravenous immunoglobulin, steroids, cyclosporine, broad-spectrum antimicrobial therapy, and finally with the anti-IL-6 drug tocilizumab. WD was suspected for the presence of adrenal calcifications and it was confirmed by LAL enzyme activity and by molecular analysis of LIPA. Plasma oxysterols cholestan-3β,5ι,6β-triol (C-triol), and 7-ketocholesterol (7-KC) were markedly increased. Sebelipase alfa was started with progressive amelioration of biochemical and clinical features. The child died from sepsis, 2 months after sebelipase discontinuation requested by parents. Our case shows the importance of an early diagnosis of WD and confirms the difficulty to reach a diagnosis in the HLH phenotype. Sebelipase alpha is an effective treatment for LAL deficiency, also in children affected by WD. Further data are necessary to confirm the utility of measuring plasma c-triol as a biochemical marker of the disease
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses
Alongside vaccines, antiviral drugs are becoming an integral part of our response to the SARS-CoV-2 pandemic. Nirmatrelvir-an orally available inhibitor of the 3-chymotrypsin-like cysteine protease-has been shown to reduce the risk of progression to severe COVID-19. However, the impact of nirmatrelvir treatment on the development of SARS-CoV-2-specific adaptive immune responses is unknown. Here, by using mouse models of SARS-CoV-2 infection, we show that nirmatrelvir administration blunts the development of SARS-CoV-2-specific antibody and T cell responses. Accordingly, upon secondary challenge, nirmatrelvir-treated mice recruited significantly fewer memory T and B cells to the infected lungs and mediastinal lymph nodes, respectively. Together, the data highlight a potential negative impact of nirmatrelvir treatment with important implications for clinical management and might help explain the virological and/or symptomatic relapse after treatment completion reported in some individuals
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both
Background and objective: Chronic obstructive pulmonary disease (COPD) and heart failure (HF) mutually increase the risk of being present in the same patient, especially if older. Whether or not this coexistence may be associated with a worse prognosis is debated. Therefore, employing data derived from the REPOSI register, we evaluated the clinical features and outcomes in a population of elderly patients admitted to internal medicine wards and having COPD, HF or COPDâ+âHF. Methods: We measured socio-demographic and anthropometric characteristics, severity and prevalence of comorbidities, clinical and laboratory features during hospitalization, mood disorders, functional independence, drug prescriptions and discharge destination. The primary study outcome was the risk of death. Results: We considered 2,343 elderly hospitalized patients (median age 81 years), of whom 1,154 (49%) had COPD, 813 (35%) HF, and 376 (16%) COPDâ+âHF. Patients with COPDâ+âHF had different characteristics than those with COPD or HF, such as a higher prevalence of previous hospitalizations, comorbidities (especially chronic kidney disease), higher respiratory rate at admission and number of prescribed drugs. Patients with COPDâ+âHF (hazard ratio HR 1.74, 95% confidence intervals CI 1.16-2.61) and patients with dementia (HR 1.75, 95% CI 1.06-2.90) had a higher risk of death at one year. The Kaplan-Meier curves showed a higher mortality risk in the group of patients with COPDâ+âHF for all causes (pâ=â0.010), respiratory causes (pâ=â0.006), cardiovascular causes (pâ=â0.046) and respiratory plus cardiovascular causes (pâ=â0.009). Conclusion: In this real-life cohort of hospitalized elderly patients, the coexistence of COPD and HF significantly worsened prognosis at one year. This finding may help to better define the care needs of this population
How future surgery will benefit from SARS-COV-2-related measures: a SPIGC survey conveying the perspective of Italian surgeons
COVID-19 negatively affected surgical activity, but the potential benefits resulting from adopted measures remain unclear. The aim of this study was to evaluate the change in surgical activity and potential benefit from COVID-19 measures in perspective of Italian surgeons on behalf of SPIGC. A nationwide online survey on surgical practice before, during, and after COVID-19 pandemic was conducted in March-April 2022 (NCT:05323851). Effects of COVID-19 hospital-related measures on surgical patients' management and personal professional development across surgical specialties were explored. Data on demographics, pre-operative/peri-operative/post-operative management, and professional development were collected. Outcomes were matched with the corresponding volume. Four hundred and seventy-three respondents were included in final analysis across 14 surgical specialties. Since SARS-CoV-2 pandemic, application of telematic consultations (4.1% vs. 21.6%; pâ<â0.0001) and diagnostic evaluations (16.4% vs. 42.2%; pâ<â0.0001) increased. Elective surgical activities significantly reduced and surgeons opted more frequently for conservative management with a possible indication for elective (26.3% vs. 35.7%; pâ<â0.0001) or urgent (20.4% vs. 38.5%; pâ<â0.0001) surgery. All new COVID-related measures are perceived to be maintained in the future. Surgeons' personal education online increased from 12.6% (pre-COVID) to 86.6% (post-COVID; pâ<â0.0001). Online educational activities are considered a beneficial effect from COVID pandemic (56.4%). COVID-19 had a great impact on surgical specialties, with significant reduction of operation volume. However, some forced changes turned out to be benefits. Isolation measures pushed the use of telemedicine and telemetric devices for outpatient practice and favored communication for educational purposes and surgeon-patient/family communication. From the Italian surgeons' perspective, COVID-related measures will continue to influence future surgical clinical practice
- âŚ